Innovative Woundcare Products
Graftjacket Regenerative Tissue Matrix
Graftjacket® regenerative tissue matrix (RTM) provides an intact, fenestrated human acellular scaffold for wounds such as diabetic foot ulcers (DFUs). It is appropriate for use in both superficial and deep wounds.
Developed specifically for wounds, Graftjacket®RTM for wounds may help reduce overall wound healthcare costs. Through its regenerative mechanism of action, Graftjacket® RTM becomes repopulated with the patient’s own cells and is remodeled into functional host tissue, resulting in a like-for-like replacement of missing dermal tissue
Bioweld1 : Tissue Welding
Cold plasma has many proven benefits for tissues, and IonMed’s improved technology has the potential to bring these benefits to the operating room.
What is cold plasma?
- Plasma is a gas in which a certain portion of the particles are ionized. Under the influence of electricity, it may form structures such as beams.
- Cold plasma generates temperatures <40°C (vs. “thermal plasma” >80°C). In contrast to thermal systems (such as “as argon plasma coagulation” and other platforms such as lasers), non-thermal plasmas have very little effect on the surrounding healthy tissue
- Enables contactless, pain-free, non-invasive and pure physical application
Known impacts of cold plasma on tissues:
- No thermal effects, cooking effects, other “collateral damage”
- Enhances hemostasis
- Promotes neovascularization and angiogenesis
- Promotes re-epithelization and may promote wound healing in a dose-dependent manner
- Bactericidal and disinfectant
- Oncocidal (anti cancer effects)
ENLUXTRA “Smart” Wound Dressing is the first and only self-regulating super-absorbent fiber dressing with the highest adaptive absorbency and built-in adaptive hydration function.
With its variable local functionality and superabsorbency ENLUXTRA works equally well for open wounds of any etiology, any stage from earliest to latest, and any wound drainage level – from minimal to highest.
- Dressing material acts according to the feedback from the underlying wound tissues.
- Maceration AND desiccation prevention. Dynamically balances the evolving moist wound environment, providing hydration or absorption depending on the needs of wound and peri-wound skin.
- Self-Adaptive dressing supports granulation, re-epithelialization and new skin remodeling simultaneously within the wound, which results in less scarring and improves appearance.
- Absorbs 1500% of its own weight and locks the fluid in. The absorbed exudate is not released under high pressure (body weight) or compression wrap.
- Painless. Non-adhering to the wound. Reduces odor.
- Has outstanding mechanical integrity.
- Serves as a microbial and strike through barrier.
- Does not support bacterial growth in the wound or inside itself.
- Self-Adaptive Dressing outperforms and makes most single-function dressings obsolete.
- Stays up to 7 days.
- Easy application.
WOUNDCHEK™ Protease Status, the world’s first and only point of care test to detect EPA (elevated protease activity), was launched in 2012 and cleared for sale in Europe, the Middle East, South Africa, and Canada. WOUNDCHEK™ Protease Status will help clinicians establish within minutes which wounds may most benefit from a protease modulating therapy, ensuring appropriate and targeted use of these therapies.
Mechanical debriding agent
Patented Monofilament Fibre Technology
- 18 million monofilament fibres
- Cut to a specific angle and length
- Soft and conformable – gentle on patients
- Angled tips reach uneven areas of the skin or wound bed
- Lifts up debris, superficial slough and exudate quickly
- Binds it within the pad
- Removes barriers to healing
- Leaves the area clear and promotes development of healthy tissue
- Won’t damage any new granulation tissue and epithelial cells
Procellera® is the only antimicrobial wound dressing powered by advanced microcurrent technology, designed to enhance the power of the body’s natural electrical healing process.
Designed to mimic physiologic electric currents, Procellera®’s imbedded microcell batteries generate microcurrents in the presence of a conductive medium to harness the power of electricity for enhanced wound healing.
• Generates physiologic levels of microcurrent (2-10μA) that are known to be necessary for healing1
• Flexible and portable with no need for external power source.
CureXcell® is comprised of a mixture of white blood cells including monocytes/macrophages, neutrophils and lymphocytes obtained from young (18-40 yrs old) healthy donor blood which is activated by a safe and simple yet patented process. CureXcell® replenishes the imbalanced inflammatory environment in the non-healing wound with functionally-active immune cells which release the necessary growth factors and are capable of phagocytosis of bacteria and dead cells in the wound bed, processes that are important for healing.
By recreating the natural environment for wound healing, the appropriate cell activities and factor secretions are maintained as required during each of the stages of wound healing and assist in the wound’s debridement. What gives CureXcell® an additional breakthrough edge is the precise balance of important immune cells in an activated state required to initiate the healing process. Once the process is started, CureXcell® stimulates the patient’s own body to complete the healing process.
Organovo’s bioprinting process centers around the identification of key architectural and compositional elements of a target tissue, and the creation of a design that can be utilized by a bioprinter to generate that tissue in the laboratory environment.
Once a tissue design is established, the first step is to develop the bioprocess protocols required to generate the multi-cellular building blocks—also called bio-ink—from the cells that will be used to build the target tissue.
The bio-ink building blocks are then dispensed from a bioprinter, using a layer-by-layer approach that is scaled for the target output. Bio-inert hydrogel components may be utilized as supports, as tissues are built up vertically to achieve three-dimensionality, or as fillers to create channels or void spaces within tissues to mimic features of native tissue.
The bioprinting process can be tailored to produce tissues in a variety of formats, from micro-scale tissues contained in standard multi-well tissue culture plates, to larger structures suitable for placement onto bioreactors for biomechanical conditioning prior to use.